Back to VANGUARD GROUP INC VANGUARD GROUP INC

ALNYALNY
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in ALNYLAM PHARMACEUTICALS INC

As of its last 13F, for Q4 2025, Vanguard Group held 13,553,932 shares of ALNY (Alnylam Pharmaceuticals), worth $5.4B. It reduced the position by 11,520 shares (-0.1%) from Q3 2025. Vanguard Group held ALNY from Q3 2024 to Q4 2025, across 6 quarterly 13F filings. ALNY was 0.1% of Vanguard Group's reported 13F portfolio.

Current Value

$5.4B

Current Shares

13.6M

Total Value Change

+$1.9B

Total Shares Change

+918,836

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Decreased
13.6M
-0.1%
$5.4B0.1%$397.65
0
2025-Q3
Increased
13.6M
+2.0%
$6.2B0.1%$456.00
33
2025-Q2
Increased
13.3M
+1.8%
$4.3B0.1%$326.09
32
2025-Q1
Increased
13.1M
+2.5%
$3.5B0.1%$270.02
33
2024-Q4
Increased
12.7M
+0.8%
$3B0.1%$235.31
32
2024-Q3
First report
12.6M
-
$3.5B0.1%$275.03
0

Other major holders of ALNY: FMR LLC, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used